Wells Fargo & Company Ishares Tr Genomics Immunology Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Wells Fargo & Company holds 12,949 shares of IDNA stock, worth $296,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,949
Previous 1,922
573.73%
Holding current value
$296,661
Previous $47,000
523.4%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IDNA
# of Institutions
66Shares Held
1.88MCall Options Held
0Put Options Held
0-
Ubs Group Ag429KShares$9.82 Million0.0% of portfolio
-
Morgan Stanley New York, NY320KShares$7.33 Million0.0% of portfolio
-
Wharton Business Group, LLC Malvern, PA271KShares$6.2 Million0.28% of portfolio
-
Bank Of America Corp Charlotte, NC211KShares$4.83 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA96.4KShares$2.21 Million0.0% of portfolio